Hemochromatosis: Genetics and pathophysiology

被引:90
作者
Beutler, E [1 ]
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
来源
ANNUAL REVIEW OF MEDICINE | 2006年 / 57卷
关键词
hepcidin; HFE; iron; ferroportin; penetrance;
D O I
10.1146/annurev.med.57.121304.131310
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A number of genetic disorders can result in the accumulation of excess iron in the body. These causes of hereditary hemochromatosis include defects in genes encoding HFE, transferrin receptor 2, ferroportin, hepcidin, and hemajuvelin. Hepcidin, with its cognate receptor, ferroportin, has emerged as a central regulator of iron homeostasis; all of the known causes of hemochromatosis appear to prevent this system from functioning normally. The most common form of primary hemochromatosis is that caused by C282Y mutation of the HFE gene. This mutation is most prevalent among Northern Europeans. Although the frequency of the homozygous genotype is approximately 5 per 1000, the disease itself is quite rare because the clinical penetrance of the genotype is very low.
引用
收藏
页码:331 / 347
页数:17
相关论文
共 110 条
  • [71] Merryweather-Clarke AT, 1999, NAT GENET, V23, P271, DOI 10.1038/15452
  • [72] Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload
    Mims, MP
    Guan, YL
    Pospisilova, D
    Priwitzerova, M
    Indrak, K
    Ponka, P
    Divoky, V
    Prchal, JT
    [J]. BLOOD, 2005, 105 (03) : 1337 - 1342
  • [73] Disruption of ferroportin 1 regulation causes dynamic alterations in iron homeostasis and erythropoiesis in polycythaemia mice
    Mok, H
    Jelinek, J
    Pai, S
    Cattanach, BM
    Prchal, JT
    Youssoufian, H
    Schumacher, A
    [J]. DEVELOPMENT, 2004, 131 (08): : 1859 - 1868
  • [74] HFE mutations analysis in 711 hemochromatosis probands:: Evidence for S65C implication in mild form of hemochromatosis
    Mura, C
    Raguenes, O
    Férec, C
    [J]. BLOOD, 1999, 93 (08) : 2502 - 2505
  • [75] Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
    Nemeth, E
    Valore, EV
    Territo, M
    Schiller, G
    Lichtenstein, A
    Ganz, T
    [J]. BLOOD, 2003, 101 (07) : 2461 - 2463
  • [76] Hepcidin is decreased in TFR2 hemochromatosis
    Nemeth, E
    Roetto, A
    Garozzo, G
    Ganz, T
    Camaschella, C
    [J]. BLOOD, 2005, 105 (04) : 1803 - 1806
  • [77] Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
    Nemeth, E
    Tuttle, MS
    Powelson, J
    Vaughn, MB
    Donovan, A
    Ward, DM
    Ganz, T
    Kaplan, J
    [J]. SCIENCE, 2004, 306 (5704) : 2090 - 2093
  • [78] IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
    Nemeth, E
    Rivera, S
    Gabayan, V
    Keller, C
    Taudorf, S
    Pedersen, BK
    Ganz, T
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (09) : 1271 - 1276
  • [79] The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation
    Nicolas, G
    Chauvet, C
    Viatte, L
    Danan, JL
    Bigard, X
    Devaux, I
    Beaumont, C
    Kahn, A
    Vaulont, S
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (07) : 1037 - 1044
  • [80] Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice
    Nicolas, G
    Bennoun, M
    Devaux, I
    Beaumont, C
    Grandchamp, B
    Kahn, A
    Vaulont, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (15) : 8780 - 8785